CFO Eliran Glazer reported a stable net dollar retention rate of 110% for Q1 2024 and attributed $25 million in anticipated revenue for FY 2024 to pricing adjustments. He confirmed a gross margin of ...
Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback